6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
5m ago	Zacks Small-Cap Research Raises FatPipe (NASDAQ:FATN) Valuation from $6.00 to $6.40 per Share Following Preliminary Fiscal Fourth Quarter Business Update
5m ago	MEDX HOLDINGS ANNOUNCES Q1 2026 HIGHLIGHTS, MULTI-CITY EXPANSION, AND CORPORATE ACTION TO REBRAND AS DAZED INC. (TICKER: DAZE)
5m ago	VS Media Enters the AI Smart Living Sector to Explore New Growth Opportunities
32m ago	Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch
32m ago	Surface Transforms plc – in Administration, Sale of Business and Assets

About

0.02AUD+0.00 +5.00%

Closed • Updated at 17:07 GMT+00:00

Market Cap$50.63M

Volume393.0K

Beta1.30

RSI54.48

Gross Margin-56.45%

Health ServicesMedical/Nursing Services

Radiopharm Theranostics Limited — investor relations, events, news, and company updates on 6ix.

Latest News

Radiopharm Theranostics Reports Business Update

Radiopharm Theranostics Presents Initial Findings from Phase 1 First-in-Human HEAT Clinical Trial for 177Lu-RAD202 in HER2+ Solid Tumors at American Association for Cancer Research 2026

Radiopharm Theranostics Completes Enrollment in U.S. Phase 2b Imaging Trial of RAD 101 for Diagnosis of Brain Metastases

RAD Completes Enrollment in Phase 2b Trial of RAD 101

Radiopharm Theranostics Advances to Cohort 3 in 177Lu-RAD202 Phase 1 Dose Escalating Clinical Trial

Community Chat

Ask AI